These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6678455)

  • 1. [Antacid capacity, sodium content and osmolarity of various antacids].
    Csendes A; Hurtado C; Antezana C; Espinoza M
    Rev Med Chil; 1983 Nov; 111(11):1134-8. PubMed ID: 6678455
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
    Gombatz VW
    Clin Ther; 1984; 6(2):151-4. PubMed ID: 6705010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of liquid antacid products.
    Sherrill MC; Rudd GD
    Am J Hosp Pharm; 1982 Feb; 39(2):300-2. PubMed ID: 7058802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sodium content of liquid antacid preparations].
    Herzog P; Walther C; Holtermüller KH
    Dtsch Med Wochenschr; 1987 Feb; 112(8):302-4. PubMed ID: 3816604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neutralizing capacity and sodium content of antacid brands on the Kenyan market.
    Kibwage IO; Machine A; Hagos B; Hoogmartens J
    East Afr Med J; 1995 Mar; 72(3):194-7. PubMed ID: 7796775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium and potassium levels in antacids.
    Yokel RA
    Am J Hosp Pharm; 1977 Feb; 34(2):200-2. PubMed ID: 842549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of neutralizing properties of antacid preparations. Part 5: Dissolution kinetics of dihydroxyaluminum aminoacetate.
    Kokot Z
    Pharmazie; 1989 Apr; 44(4):274-5. PubMed ID: 2772001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of neutralizing properties of antacid preparations. Part 4: Application of Weibull distribution function to neutralization of dihydroxyaluminum sodium carbonate.
    Kokot Z
    Pharmazie; 1988 Jul; 43(7):481-3. PubMed ID: 3222278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antacids and HCl.
    Malagelada JR; Carlson GL
    Scand J Gastroenterol Suppl; 1982; 75():10-2. PubMed ID: 6293042
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro buffering capacities of proprietary non-particulate antacids available in New Zealand.
    Watts DW
    Anaesth Intensive Care; 1994 Apr; 22(2):184-6. PubMed ID: 8210023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the neutralising capacity of eight brands of antacids.
    Hagos B; Nganga JN; Juma FD; Ndegwa P
    East Afr Med J; 1989 Jun; 66(6):408-10. PubMed ID: 2791947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antacids: A comparison of their in vitro neutralizing capacity in hydrochloric acid and in acidified peptone solution (author's transl)].
    Walther C; Herzog P; Hissnauer KH; Kühl HJ; Holtermüller KH
    Z Gastroenterol; 1982 May; 20(5):263-72. PubMed ID: 7102017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of intelligent tablets with an antacid effect.
    Bajdik J; Korbely A; Pintye-Hódi K
    Pharm Dev Technol; 2009; 14(5):471-5. PubMed ID: 19552554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles for development of antacids.
    Pilbrant A
    Scand J Gastroenterol Suppl; 1982; 75():32-6. PubMed ID: 6959248
    [No Abstract]   [Full Text] [Related]  

  • 16. Antacid tablets strength and neutralization rate.
    Dondi G; Binda ML; Caramella C; Colombo P; Conte U; La Manna A
    Pharm Acta Helv; 1983; 58(9-10):259-62. PubMed ID: 6634815
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro evaluation of antacids.
    Engel GB
    N Z Med J; 1969 Feb; 69(441):80-2. PubMed ID: 5252206
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium content and neutralising capacity of some commonly used antacids.
    Barry RE; Ford J
    Br Med J; 1978 Feb; 1(6110):413. PubMed ID: 23886
    [No Abstract]   [Full Text] [Related]  

  • 19. An evaluation of As-Di-Sol primojel and polyplasdone XL as adjuvants in antacid tablets.
    Jovanović M; Samardzić Z; Djurić Z; Zivanović L
    Pharmazie; 1988 Oct; 43(10):727. PubMed ID: 3212024
    [No Abstract]   [Full Text] [Related]  

  • 20. Some problems with antacids.
    Barry RE
    J Int Med Res; 1978; 6 Suppl 1():11-7. PubMed ID: 750251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.